In Celebration of the Historic Legalization of Hemp, Irwin Naturals Founder Pledges to Give Away $1 Million of Free CBD

This information was provided by prnewswire

Send your Press Release here.

Klee Irwin, is on a mission to spread health to the country by making CBD affordable and accessible for all Americans

LOS ANGELES, Dec. 13, 2018 /PRNewswire/ — Klee Irwin, founder of Irwin Naturals and author of Pain Nation, announced today that, in celebration of the federal legalization of hemp, he is pledging to give away $1,000,000* worth of CBD products when the bill is signed by President Trump.

“Our mission is to spread health to the world through plant medicine. And I can’t think of a better way to celebrate than to give something back to our Country – a nation in an emergency state of emotional and physical health,” said Klee Irwin, founder of Irwin Naturals. “There are, arguably, five plant molecules that have changed the course of how we eat and live, and which have had a massive impact (some positive some not so much) on human history. These are alcohol, sugar, theobromine from chocolate, nicotine and caffeine. CBD will be the sixth. It will become ubiquitous in our food supply because it will have a profound impact on our health and wellness – on our society, really.”

The same day President Trump signs the bill into law, Irwin Naturals will start giving away $1,000,000 of free CBD on a first come first serve basis. Consumers can sign up to get their free CBD sample https://irwinnaturals.com/CBD-signup while supplies last. Irwin Naturals will pay for everything except shipping, handling and processing costs of $9.95.

Under the leadership of Senate Majority Leader Mitch McConnell (R-Kentucky), Mike Conaway (R-Texas), Pat Roberts (R- Kan.), Collin Peterson (D-Minn.), James Comer (D-Kentucky) Heidi Heitkamp (D-ND) Debbie Stabenow (D-Mich.) and many others, the bipartisan 2018 Farm Bill (which also includes the Hemp Farming Act of 2018 legalizing hemp and hemp derivatives for the first time in over 80 years) was approved by the Senate and the House and now awaits President Trumps signature.

Emerald contributor since March 2012

Comments

Your email address will not be published.